Journals / The Journal of Pediatric Research / 2020 / Cilt: 7 - Sayı: 1

Occurrence of Unexpected Adverse Reactions to Vaccines in Children with Mastocytosis

Pages
81–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients that experience a severe postvaccinationreaction such as anaphylaxis, a modified schedule with single vaccine administration is a safer approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Children with cutaneous or systemic mastocytosis may experience severe manifestations of mast cell mediator release includinganaphylaxis.
📊
Key Findings & Data:The perceived risk for adverse vaccine reactions creates concern among parents and pediatricians regarding modification of theroutine vaccine schedule for safety.Materials and Methods: Using the National Institutes of Health (NIH) Biomedical Translational Research Information System and ClinicalResearch Information System, we conducted a retrospective chart review of 94 children ≤18 years of age, evaluated at NIH with mastocytosis.Based on the recommended childhood immunization schedule, we estimated that these 94 patients received approximately 2,136 vaccinations.Post vaccination reactions were determined as expected or unexpected according to the centers for disease control (CDC) parameters forvaccine-associated events.Results: Eighty-four patients (89.4%) had no reports of moderate-severe post-vaccination reactions.
💡
Conclusion & Impact:In patients that experience a severe postvaccinationreaction such as anaphylaxis, a modified schedule with single vaccine administration is a safer approach.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: Children with cutaneous or systemic mastocytosis may experience severe manifestations of mast cell mediator release includinganaphylaxis. The perceived risk for adverse vaccine reactions creates concern among parents and pediatricians regarding modification of theroutine vaccine schedule for safety.Materials and Methods: Using the National Institutes of Health (NIH) Biomedical Translational Research Information System and ClinicalResearch Information System, we conducted a retrospective chart review of 94 children ≤18 years of age, evaluated at NIH with mastocytosis.Based on the recommended childhood immunization schedule, we estimated that these 94 patients received approximately 2,136 vaccinations.Post vaccination reactions were determined as expected or unexpected according to the centers for disease control (CDC) parameters forvaccine-associated events.Results: Eighty-four patients (89.4%) had no reports of moderate-severe post-vaccination reactions. Eleven reactions after vaccination werereported in 10 of 94 patients (10.6%), of which four patients had unexpected reactions (4.3%). Unexpected reactions included facial swelling,flushing and exacerbation of skin lesions which are not reported as possible vaccine reactions by the CDC. One patient was treated foranaphylaxis 2 hours post-varicella vaccine administration. Five patients with a history of anaphylaxis and a mean tryptase level of 115 ng/mLdid not report vaccine-induced reactions.Conclusion: Children with mastocytosis in this study did not experience a higher rate of adverse vaccine reactions compared to the generalpopulation. Anaphylaxis to other causes was not a risk factor for an untoward vaccine response. In patients that experience a severe postvaccinationreaction such as anaphylaxis, a modified schedule with single vaccine administration is a safer approach.

🔖

Cite This Article

ABUHAY, H., CLARK, A. S., CARTER, M. C. (2020). Occurrence of Unexpected Adverse Reactions to Vaccines in Children with Mastocytosis. The Journal of Pediatric Research, Cilt: 7 - Sayı: 1, 81–86. https://ajindex.com/articles/362737

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria. Eur J Clin Invest 2007;37:435-53
  2. Broesby-Olsen S, Carter M, Kjaer HF, et al. Pediatric Expression of Mast Cell Activation Disorders. Immunol Allergy Clin North Am 2018;38:365-377
  3. Hartmann K, Escribano L, Grattan C, et al. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 2016;137:35-45
  4. Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am 2014;34:207-18
  5. Alvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 2012;67:813-21
  6. Parente R, Pucino V, Magliacane D, et al. Evaluation of vaccination safety in children with mastocytosis. Pediatr Allergy Immunol 2017;28:93-5
  7. Bankova LG, Walter JE, Iyengar SR, Lorenzo ME, Hornick JL, Castells MC. Generalized Bullous Eruption after Routine Vaccination in a Child with Diffuse Cutaneous Mastocytosis. J Allergy Clin Immunol Pract 2013;1:94-6
  8. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63:226-32
  9. Gupta M, Akin C, Sanders GM, Chan MP, Ross CW, Castells MC. Blisters, Vaccines, and Mast Cells: A Difficult Case of Diffuse Cutaneous Mastocytosis. The Journal of Allergy and Clinical Immunology: In Practice 2019;7:1370-2
  10. Koh MJ, Chong WS. Red Plaque After Hepatitis B Vaccination. Pediatr Dermatol 2008;25:381-2
  11. Poulton JK, Kauffman CL, Lutz LL, Sina B. Solitary mastocytoma arising at a hepatitis B vaccination site. Cutis 1999;63:37-40
  12. Center for Disease Control and Prevention. Possible Side-effects from Vaccines. Vol 2019. ed2018
  13. Center for Disease Control and Prevention. Resource Library: Prior Years’ Child/Adolescent Immunization Schedules. Vol 20182018
  14. Nilsson L, Brockow K, Alm J, et al. Vaccination and allergy: EAACI position paper, practical aspects. Pediatr Allergy Immunol 2017;28:628-40.